Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $1.06 Million
107,027 New
107,027 $0
Q3 2022

Nov 14, 2022

BUY
$8.57 - $11.57 $85,631 - $115,607
9,992 Added 10.29%
107,066 $952,000
Q2 2022

Aug 15, 2022

SELL
$8.84 - $11.64 $113,594 - $149,574
-12,850 Reduced 11.69%
97,074 $968,000
Q1 2022

May 11, 2022

SELL
$10.07 - $11.93 $31,116 - $36,863
-3,090 Reduced 2.73%
109,924 $1.27 Million
Q4 2021

Feb 11, 2022

BUY
$7.95 - $11.24 $10,700 - $15,129
1,346 Added 1.21%
113,014 $1.26 Million
Q3 2021

Nov 12, 2021

SELL
$9.22 - $12.44 $1.18 Million - $1.59 Million
-127,846 Reduced 53.38%
111,668 $1.03 Million
Q2 2021

Aug 11, 2021

BUY
$9.91 - $12.78 $140,424 - $181,092
14,170 Added 6.29%
239,514 $2.69 Million
Q1 2021

May 13, 2021

BUY
$10.44 - $12.22 $96,204 - $112,607
9,215 Added 4.26%
225,344 $2.39 Million
Q4 2020

Feb 09, 2021

SELL
$9.3 - $11.77 $167,465 - $211,942
-18,007 Reduced 7.69%
216,129 $2.34 Million
Q3 2020

Nov 12, 2020

BUY
$7.59 - $10.8 $68,082 - $96,876
8,970 Added 3.98%
234,136 $2.28 Million
Q2 2020

Aug 12, 2020

SELL
$7.96 - $11.54 $460,501 - $667,612
-57,852 Reduced 20.44%
225,166 $1.79 Million
Q1 2020

May 06, 2020

SELL
$7.69 - $11.68 $36,281 - $55,106
-4,718 Reduced 1.64%
283,018 $2.46 Million
Q4 2019

Feb 14, 2020

SELL
$9.09 - $11.89 $72,947 - $95,417
-8,025 Reduced 2.71%
287,736 $3.25 Million
Q3 2019

Nov 07, 2019

SELL
$9.66 - $12.36 $24,864 - $31,814
-2,574 Reduced 0.86%
295,761 $3.21 Million
Q2 2019

Aug 12, 2019

BUY
$9.32 - $12.98 $114,403 - $159,329
12,275 Added 4.29%
298,335 $2.8 Million
Q1 2019

May 14, 2019

SELL
$10.35 - $13.06 $39,795 - $50,215
-3,845 Reduced 1.33%
286,060 $3.51 Million
Q4 2018

Feb 11, 2019

SELL
$11.64 - $15.41 $328,376 - $434,731
-28,211 Reduced 8.87%
289,905 $3.43 Million
Q3 2018

Nov 09, 2018

SELL
$12.65 - $15.15 $106,462 - $127,502
-8,416 Reduced 2.58%
318,116 $0
Q2 2018

Aug 06, 2018

SELL
$13.05 - $15.45 $6,237 - $7,385
-478 Reduced 0.15%
326,532 $4.87 Million
Q1 2018

May 15, 2018

BUY
$12.0 - $14.45 $28,860 - $34,752
2,405 Added 0.74%
327,010 $4.27 Million
Q4 2017

Feb 09, 2018

BUY
$11.65 - $13.35 $3.78 Million - $4.33 Million
324,605
324,605 $4.09 Million

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.